1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"Clinical Trials to Validate AI-Driven Drug Repurposing RFP Grant" is currently closed and not accepting applications.
Clinical Trials to Validate AI-Driven Drug Repurposing RFP Grant is sponsored by Cures Within Reach. Invites submissions for Phase I and IIA trials focusing on AI-driven repurposing of already approved therapies for unsolved diseases.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Funding Opportunity: Clinical Trials to Validate AI-Driven Drug Repurposing Funding Opportunity: Clinical Trials to Validate AI-Driven Drug Repurposing Cures Within Reach (CWR) is a non-profit organization that focuses on accelerating the development of new treatments for diseases by repurposing existing drugs, devices, and other therapies.
They do this by funding proof-of-concept clinical trials that test these therapies for new indications, effectively speeding up the process of finding new treatments for patients. CWR has announced a new Request for Proposals (RFP) for Clinical Trials to Validate AI-Driven Drug Repurposing .
CWR is accepting budgets of up to $100,000 for proof of concept, Phase I or Phase IIA clinical trials that have AI-generated data as part of the preclinical support.
Projects must repurpose already approved drugs, biologics or eligible cellular/gene therapies, with a preference for off patent therapies Any unsolved disease is eligible, with a preference for rare diseases PIs from anywhere in the world and at any career stage can apply; there's no limit to the number of submissions from any institution or PI Any AI model is eligible to generate preclinical supporting data, with a preference for openly accessible models and for models developed by nonprofits/government CWR has created a document " Potential AI Model Resources for CWR " solely to provide options to PIs and as just one resource of potential AI models that could be used as part of an RFP submission Budgets of up to $100,000, including the required 10% institutional match, are accepted; additional funds are available for community engagement View the RFP at cureswithinreach.
org . LOI submissions are due by August 25, 2025 on ProposalCentral using the Non-Disease Specific Repurposing Research program; top scoring LOIs will be invited to submit a full proposal. View news related to policies and regulations Have news or an announcement to share?
Contact Michelle Maclay at michelle_maclay@med. unc. edu
According to the current listing, eligibility includes: Open to all eligible applicants. Confirm the full requirements in the official notice before applying.
The current listing shows up to $100,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was August 25, 2025, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Clinical Trials to Validate AI-Driven Drug Repurposing RFP Grant is funded by Cures Within Reach. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Clinical Repurposing for Veterans Initiative is sponsored by Cures Within Reach. This initiative focuses on finding and funding clinical repurposing trials that address unmet and high-priority medical needs of veterans and active military, including brain injuries. This is a very strong fit for a nonprofit focused on neurological conditions and veterans.
Funding Opportunities / RFPs (Cures Within Reach) is sponsored by Cures Within Reach. Cures Within Reach's mission is to improve patient quality and length of life by leveraging the speed, safety and cost-effectiveness of testing already approved therapies for new indications that serve philanthropic and/or commercial uses, driving more treatments to more patient…
AI Validation - Clinical Trials to Validate AI-Driven Drug Repurposing is sponsored by Cures Within Reach. This program supports investigator-initiated, proof-of-concept, Phase I or Phase IIA clinical trials to validate AI-driven repurposing opportunities for approved therapies in any unsolved disease. Eligible trials must include AI-generated data as part of the preclinical support.
On July 30, 2026, five food and farming nonprofits sued USDA in the Western District of Washington over grant terms and conditions that restrict what grantees may say and do — including with money that never came from the federal government. Twenty states and DC filed a parallel challenge in March. Here is what the conditions actually say and what recipients should do before their next award letter arrives.
Read articleHRSA-26-078 splits $9.1 million among roughly 10 Public Health Training Centers, with awards up to $910,000 and applications due July 17, 2026. Eligibility runs to accredited schools of public health and other nonprofit training institutions. Here's why the winning applications are the ones that can prove an existing, mapped relationship with state and local health departments — not the ones promising the slickest coursework.
Read articleThe Department of Education's May 19 final rule activates Workforce Pell on July 1, 2026, opening federal aid to short-term training programs as brief as 8 weeks. Governors and state workforce boards — not accreditors — pick the eligible industries, and only programs that pass earnings-vs-cost gates make the list.
Read article